ANTIPHOSPHOLIPID SYNDROME COLLABORATIVE REGISTRY

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目及 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 目的：本研究的目的是建立抗磷脂综合征（APS）的国家登记处。 登记研究将收集和更新APS患者和无症状抗磷脂抗体患者的临床、人口统计学和实验室数据。 研究方法和方法：在为期5年的研究中，8个研究中心预计每年招募50名患者。 参与者将接受约30-45分钟的访谈，以获得有关APS病史和特征的详细信息。 将采集并储存血液样本，以确认是否存在抗磷脂抗体。 一旦受试者被批准入组，可能会就涉及登记研究的未来研究与他们联系。 参与者没有义务参与这些研究。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. OBJECTIVE: The purpose of this study is to establish a national registry for Antiphospholipid Syndrome (APS). The registry will collect and update clinical, demographic, and update clinical, demographic, and laboratory data on individuals with APS and asymptomatic patients with antiphospholipid antibodies. RESEARCH PLAN AND METHODS: Each of the eight sites are expected to enroll 50 patients per year of the 5-year study. Participants will be interviewed for approximately 30-45 minutes to get detailed information about medical history and features of APS. A blood sample will be obtained and stored for confirmation of the presence of antiphospholipid antibodies. Once the participant has been approved for enrollment they may be contacted about future studies involving the registry. Participants are under no obligation to participate in these studies.